CVE-2024-33302: SourceCodester Product Show Room · Cross-site Scripting
Source CVE Database V5
Not known to be exploited · CVSS 5.3 Medium.
Data as of 26 Oct 2026, 17:16 UTC
- EPSS
- 0.2% chance of exploitation in 30 days – higher than 21% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:LExploitation evidence
Disclosed: evidence found.
CVE published 2 May 2024
Detectable: no evidence on record.
No public nuclei template indexed
Weaponised: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 26 Oct 2026.
What to do
AI-suggested
To mitigate CVE-2024-33302, organizations should implement strict input validation and output encoding on the 'Middle Name' field and any other user-supplied inputs to prevent script injection. Employing a web application firewall (WAF) with rules to detect and block XSS payloads can provide an additional layer of defense. Restrict access to the Add Users functionality to trusted administrators only, minimizing the risk of exploitation by low-privilege users. Conduct regular security assessments and code reviews focused on input handling to identify and remediate similar vulnerabilities. Until an official patch is released, consider isolating or disabling the vulnerable feature if feasible. Educate developers on secure coding practices related to CWE-79 to prevent recurrence. Monitoring logs for suspicious activity related to user input can help detect attempted exploitation early.
Description
SourceCodester Product Show Room 1.0 and before is vulnerable to Cross Site Scripting (XSS) via "Middle Name" under Add Users.